At UC Health, we lead the region in scientific discoveries and embrace a spirit of purpose – offering our patients and their families something beyond everyday healthcare. At UC Health, we offer hope.
Lung Volume Reduction Procedures
Lung volume reduction procedures are designed to help you breathe easier when your lungs have been damaged by COPD or Emphysema. Removing the area of the lung that is most affected by disease helps the remaining lung function more efficiently.
Cincinnati's Leader in Severe Emphysema Treatment
In our advanced emphysema program, a multidisciplinary team of pulmonologists, thoracic surgeons and thoracic anesthesiologists evaluate each individual patient's unique circumstances allowing patients to receive the best treatment plan for them.
Help Along the Way
Answers to Your Questions about Lung Volume Reduction Procedures
Lung volume reduction surgery (LVRS) is a procedure designed to help you breathe easier when your lungs have been damaged by severe COPD. The goal of the procedure is to remove or deflate the area of the lung tissue most affected by the disease, allowing the remaining lung to function more efficiently, and improve your breathing ability and quality of life.
Chronic Obstructive Pulmonary Disease (COPD) and Emphysema
Chronic obstructive lung disease (COPD) is the 3rd leading cause of death in the United States. Emphysema is a type of COPD in which the progressive destruction of the air sacs of the lungs makes it difficult to breathe. This often results in over-inflation of the lung.
Lung Volume Reduction is a procedure to reduce the size of over-inflated lung/s in patients with emphysema. This gets rid of the most damaged areas of the lung and allows areas of the lung that are more “normal” to work better. There are two types of lung volume reduction available.
- Lung volume reduction surgery (LVRS) is a surgical procedure to remove emphysematous lung tissue to reduce the size of over-inflated lung/s and allow the expansion of the remaining, often more functional lung. This is typically done by video-assisted thoracoscopic surgery (VATS) on either one or both sides.
- Bronchoscopic lung volume reduction (BLVR) is a newer minimally-invasive technique in which tiny one-way valves are placed in the lung to allow the most damaged areas of the lung to deflate.
Both procedures reduce the area of the over-expanded and damaged lung to allow the more normal remaining lung to work more efficiently. This allows patients to breathe easier and have a better quality of life. Whether you are a candidate for one of these procedures will be determined by our team of experts.
Lung Volume Reduction Surgery (LVRS) is most commonly done with VATS (video-assisted thoracoscopy surgery). This involves making several (three to four) small incisions where a camera and instruments are placed to do the surgery. The ribs are not spread with this approach. LVRS can be done on one or both sides depending on your situation. General anesthesia is required and patients are in the hospital for 5-7 days.
Bronchoscopic Lung Volume Reduction (BLVR) is done using a small lighted scope with a camera inserted through your mouth while under general anesthesia. Tiny one-way valves (endobronchial valves) are inserted into the most damaged lung, blocking air from entering but allowing mucous secretions and air to escape. This is typically done on one side. The valves are intended to be kept indefinitely, although can be removed if needed.
Compared to lung volume reduction surgery (LVRS), BLVR is a less invasive procedure. In addition, there are no incisions which can lead to faster recovery and fewer risks compared to a surgical procedure.
In general, the best candidates for a successful lung volume reduction procedure tend to be those who:
Have severe lung damage (emphysema)
Are somewhat physically active and able to exercise
Are former smokers (not currently smoking)
Have been diagnosed with COPD for at least two years
Have no other significant health conditions
An ideal candidate for the LVRS procedure will:
Have severe lung damage (emphysema), particularly in the upper part of the lung
Have completed a pulmonary rehabilitation program
Have not smoked for at least 4 months
Do not have severe heart disease or other health problems that make surgery higher risk
Do not require larger doses of steroids (prednisone), >20 mg daily
Do not require over 6L of oxygen at rest
Who may not be a candidate for Lung Volume Reduction Surgery?
People who are born with an inherited form of emphysema, called alpha-1-antitrypsin deficiency-related emphysema, are not likely to benefit from lung volume reduction surgery. A lung transplant may be a better treatment option than lung volume reduction surgery for these individuals.
An ideal candidate for the BLVR procedure will:
Have severe lung damage (emphysema)
Have completed a pulmonary rehabilitation program within 2 years
Have not smoked for at least 4 months and to commit to not smoking after valve placement, as valves may stop working with continued lung destruction
Do not have severe heart disease or other health problems that make the procedure higher risk
Do not have frequent COPD exacerbations (frequent courses of prednisone/steroids)
Do not require larger doses of steroids (prednisone), >15 mg daily
BLVR can be performed in upper or lower lobe predominant emphysema, alpha-1 antitrypsin disease, and certain patients with homogenous emphysema
Before undergoing LVR, patients must be evaluated by a pulmonologist and thoracic surgeon. This will determine if you are an ideal candidate and which procedure may be best for you.
Required preoperative testing includes:
- Pulmonary function tests
- Six-minute-walk test
- Arterial blood gas to measure levels of carbon dioxide and oxygen in the blood
- CT scans of the lungs
- Echocardiogram
- A lung perfusion scan
Other testing may be required depending on your health and specific situation. To be a candidate, you must have stopped smoking for at least 4 months and have completed a pulmonary rehabilitation program.
What are the Benefits of Lung Volume Reduction Procedures?
Both procedures can result in significant improvements in quality of life, allowing patients to breathe easier and do more. In some cases, it may even allow patients to live longer and decrease the amount of oxygen they need.
Studies have shown that lung volume reduction surgery and bronchoscopic lung volume reduction improve exercise capacity, lung function, and quality of life in selected patients when compared with people who were treated with other methods.
What are the Risks of Lung Volume Reduction Procedures?
There are some risks and common complications associated with LVRS and BLVR.
Risks for Lung volume reduction surgery (LVRS) include:
Wound infection
Prolonged air leak into the chest cavity (needing your chest tube in longer than normal)
Bleeding
Pain or numbness at the incision site
Infections such as pneumonia
Respiratory failure
Atrial fibrillation (irregular heartbeat that is usually temporary and controlled with medication)
Risks of Bronchoscopic lung volume reduction (BLVR) include:
Pneumonia
Respiratory failure
Pneumothorax (air around the lung)
COPD Exacerbation
In the days leading up to the procedure, the patient may need to undergo additional tests and imaging studies to ensure that they are healthy enough for surgery. They may also need to stop taking certain medications or make other lifestyle changes in preparation for the procedure.
Overall, the evaluation process before a lung volume reduction procedure is thorough and designed to ensure that the patient receives the safest and most effective treatment possible.
For Lung Volume Reduction Surgery (LVRS):
Patients are typically in the hospital for an average of 7 days, sometimes shorter or longer. After leaving the hospital, you will not do everything you did before surgery. Your body will need almost two months to return to a normal activity. Patients should expect to start seeing a benefit (improvement in quality of life, breathing easier) in about 3 months after surgery.
Patients are seen for follow up at 2 weeks, 6 weeks, 6 months and 1 year after the procedure and annually thereafter.
For Bronchoscopic Lung Volume Reduction (BLVR)
Patients are typically in the hospital for an average of 3 days for close monitoring after the procedure. As the area of more diseased/“bad” lung closes off and allows the good lung to open up, there is closer monitoring for complications during this time.
Your body will need around 2 weeks – although up to 6 weeks – to recover and ultimately find a benefit. There can be further gradual improvement out to 6 months, thereafter the valves are kept in place indefinitely and can undergo revision if needed. Patients are cleared to return to pulmonary rehabilitation at 2 weeks post-procedure.
Patients are followed closely with telephone calls at 1 week and 2 weeks post-procedure. They are seen in the clinic at 3 months, 6 months, and annually thereafter. We perform studies such as pulmonary function tests, 6-minute walk tests, and CT scans to ensure the valves are working as intended and the benefits are present.
For Lung Volume Reduction Surgery (LVRS):
Your body will need almost 2 months to return to a normal activity. Patients should expect to start seeing a benefit (improvement in quality of life, breathing easier) in about 3 months after surgery.
Patients are seen for follow up at 2 weeks, 6 weeks, 6 months and 1 year after the procedure and annually thereafter.
For Bronchoscopic Lung Volume Reduction (BLVR):
Your body will need around 2 weeks—although up to 6 weeks —to recover and ultimately find a benefit. There can be further gradual improvement out to 6 months, thereafter the valves are kept in place indefinitely and can undergo revision if needed.
Patients are cleared to return to pulmonary rehabilitation at 2 weeks post-procedure.
Lung volume reduction procedures can significantly improve patients' quality of life, as demonstrated by Mike's inspiring story.
After struggling with severe emphysema that left him breathless and reliant on a rescue inhaler, Mike underwent a bronchoscopic lung volume reduction procedure using Spiration® valves at UC Health.
The results were remarkable. As Mike enthusiastically shared, "Guess how many times I've used my rescue inhaler since Dr. Radchenko did the surgery? Zero times.I think that sums everything up right there. I'm able to breathe so much easier now."
This dramatic improvement in his breathing capacity allowed Mike to regain his active lifestyle, highlighting the life-changing potential of these innovative procedures for patients with severe emphysema
You can read Mike's full story here.
Why UC Health
Experience and Expertise
The Most Experienced Team
As the only certified LVRS (Lung Volume Reduction Surgery) program in the region with over 20 years of experience performing LVRS, we are dedicated to providing our patients with the best treatment options available.
JCAHO Certified
With JCAHO certification, we are one of only a handful of centers in Ohio that can provide LVR procedures to Medicare patients. While other centers may offer LVRS for non-Medicare patients, we are the only ones who can provide this service to Medicare patients.
Advanced Care for Emphysema
Our multidisciplinary, advanced emphysema program is unparalleled in the region and the country. Our experts evaluate each patient individually, considering their unique circumstances, to determine the best treatment option for them.
BLVR Started Here
We have been at the forefront of the development of bronchoscopic LVR, having been part of the initial clinical trials for this procedure. With this involvement, we have become the most experienced center in the region in providing this treatment option. We offer intervention with both valves that are available on the market and select the valve that works best for you.
Nationally-ranked Interventional Pulmonology Program
We have the most innovative doctors in the region who lead the way with ground-breaking research, new technologies and clinical trials.
U.S. News & World Report Best Hospitals 2022-23
UC Medical Center was honored as a Best Regional Hospital and received high-performing ratings for superior lung cancer and Chronic Obstructive Pulmonary Disease (COPD) care as part of U.S. News & World Report Best Hospitals 2022-23.